Podcast

Dr Javed Butler: Initiating vericiguat

Dr. Javed Butler discusses the appropriate initiation of vericiguat for patients with worsening heart failure. Vericiguat is essential for individuals already on optimal medical therapy who experience worsening heart failure, as well as those unable to reach optimal doses of foundational therapy. It can be started earlier in the treatment process to prevent disease progression and avoid advanced heart failure.

Our speakers

Dr. Javed Butler
MD, MPH, MBA, Baylor Scott and White Health.
Dr. Javed Butler is a prominent figure in cardiovascular medicine, especially known for his work on heart failure. Based in Dallas, Texas, he holds leadership positions at Baylor Scott & White, including the Maxwell A. and Gayle H. Clampitt Endowed Chair, president, and chief research executive at the Research Institute, and senior vice president at the Health system. His expertise is recognized by his fellowships in several prestigious organizations, such as the Heart Failure Society of America, the European Society of Cardiology, the American College of Cardiology, and the American Heart Association.
Dr. Javed Butler
MD, MPH, MBA, Baylor Scott and White Health.

Related content

Dr Javed Butler: Vericiguat: RRR vs. ARR

Why is considering ARR so important while we look at clinical trial data

PP-VER-IN-0233-1, September 2024

Dr Javed Butler: Vericiguat & Mortality

PP-VER-IN-0234-1, September 2024

Dr Javed Butler: Up-titrating Vericiguat

PP-VER-IN-0235-1, September 2024